Goldman Sachs Group Inc Lexicon Pharmaceuticals, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 540,207 shares of LXRX stock, worth $421,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
540,207
Previous 401,291
34.62%
Holding current value
$421,361
Previous $630,000
36.67%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding LXRX
# of Institutions
132Shares Held
238MCall Options Held
37.3KPut Options Held
144K-
Artal Group S.A. Luxembourg, N4136MShares$106 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$30.4 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.71 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.71 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$7.01 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $147M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...